Overview

Efficacy and Safety of HE10 for Dry Eye Syndrome

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of HE10 eye drop for the patients with moderate to severe dry eye syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Huons Co., Ltd.
Huons Co.,Ltd.
Treatments:
Cyclosporine
Cyclosporins